TAM
BIOSU

Terrapin Asset Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Terrapin Asset Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,000
Closed -$53.6K – 185
2022
Q4 		$53.6K Buy
+5,000
New +$50.8K 0.05% 162

Other funds holding BIOSU

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Terrapin Asset Management's BIOSU Position: Q1 2023 in Review

Terrapin Asset Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q1 2023, closing a stake of 5,000 shares — an estimated $53.6K sold.

Terrapin Asset Management first reported a position in BIOSU in Q4 2022 and held it in 1 quarter. The position peaked at $53.6K in Q4 2022. 9 funds tracked by Wall St. Rank hold BIOSU as of Q1 2023.

  • Terrapin Asset Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
  • Terrapin Asset Management sold 5,000 BioPlus Acquisition Corp. Unit shares in Q1 2023, an estimated $53.6K.
  • Terrapin Asset Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2022 and held it in 1 quarter.
  • Terrapin Asset Management's BioPlus Acquisition Corp. Unit position peaked at $53.6K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q1 2023.

Based on Terrapin Asset Management's 13F filing for Q1 2023, filed 12 May 2023.